Heartland Advisors’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$360K Sell
7,606
-72,315
-90% -$3.72M 0.02% 226
2026
Q1
$4.74M Buy
79,921
+4,930
+7% +$320K 0.24% 161
2025
Q4
$4.63M Buy
74,991
+10,615
+16% +$650K 0.25% 152
2025
Q3
$4.02M Buy
64,376
+18,851
+41% +$1.31M 0.21% 161
2025
Q2
$3.64M Buy
+45,525
New +$3.81M 0.2% 160

Other funds holding PBH

Heartland Advisors's PBH Position: Q2 2026 in Review

Heartland Advisors reduced its Prestige Consumer Healthcare (PBH) stake by 90% in Q2 2026, selling an estimated $3.72M and leaving 7,606 shares worth $360K. The position accounts for 0.02% of the portfolio, ranked #226.

Heartland Advisors first reported a position in PBH in Q2 2025 and has held it in 5 quarters since. The position peaked at $4.74M in Q1 2026. 319 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

  • Heartland Advisors held 7,606 shares of Prestige Consumer Healthcare worth $360K as of Q2 2026.
  • Heartland Advisors sold 72,315 Prestige Consumer Healthcare shares in Q2 2026, an estimated $3.72M.
  • Prestige Consumer Healthcare made up 0.02% of Heartland Advisors's portfolio in Q2 2026, its #226 holding.
  • Heartland Advisors first reported a position in Prestige Consumer Healthcare in Q2 2025 and has held it in 5 quarters since.
  • Heartland Advisors's Prestige Consumer Healthcare position peaked at $4.74M in Q1 2026.
  • 319 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on Heartland Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.